Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Aug
17
2019
California DPR Issues Cancellation Notices for Chlorpyrifos, and Establishes a Work Group to Recommend and to Develop Alternatives to Chlorpyrifos Bergeson & Campbell, P.C.
Aug
16
2019
BRAG Biobased Products Blog: August 16, 2019 Bergeson & Campbell, P.C.
Aug
16
2019
FDA Proposes New Graphic Warnings for Cigarettes Keller and Heckman LLP
Aug
15
2019
Speculative Claims Sink Cheerios Glyphosate Suit Bilzin Sumberg
Aug
15
2019
Health Care Enforcement Quarterly Roundup | Q2 2019 McDermott Will & Emery
Aug
15
2019
EPA Names Dr. Lynn Dekleva as Associate Deputy Assistant Administrator for New Chemicals Bergeson & Campbell, P.C.
Aug
15
2019
Long-Awaited CFTC v. Kraft Settlement Resolves Manipulation Allegations Bracewell LLP
Aug
15
2019
EPA Issues Guidance Regarding Prop 65 Labeling Requirements for Glyphosate Products and OEHHA Responds Bergeson & Campbell, P.C.
Aug
15
2019
Allscripts Announces $145 Million Preliminary Settlement with DOJ Related to an Investigation of Practice Fusion, a Recently Acquired EHR Company Robinson & Cole LLP
Aug
15
2019
EPA Refuses to Approve Glyphosate Labels with Proposition 65 Cancer Warning Keller and Heckman LLP
Aug
15
2019
EPA Proposes to Designate 20 Chemical Substances as Low-Priority Substances Bergeson & Campbell, P.C.
Aug
14
2019
Tainted Beef Warning Triggers TCPA Emergency Exception Squire Patton Boggs (US) LLP
Aug
14
2019
Congress Looking to Streamline CBD Drug Research Mintz
Aug
14
2019
What’s New in E-Cigarette Regulation? Epstein Becker & Green, P.C.
Aug
14
2019
FDA Issues First Warning Letter to Food Importer Under FSVP Keller and Heckman LLP
Aug
13
2019
German Chemical Industry Association Publishes Guidance on Safe Recovery and Disposal of Wastes Containing Nanomaterials Bergeson & Campbell, P.C.
Aug
13
2019
CMS Takes Another Swing at 340B Reimbursement Cuts. Will It Be Strike Three? Mintz
Aug
13
2019
Up in Smoke: The Countdown on Vape Enforcement Discretion Begins Epstein Becker & Green, P.C.
Aug
12
2019
EPA Draft Risk Evaluation for 1-BP Finds Unreasonable Risks to Workers, Occupational Non-Users, Consumers, and Bystanders under Certain Specific Uses Bergeson & Campbell, P.C.
Aug
12
2019
Legislative Efforts to Curb Sexual Harassment in the Hospitality Industry Finally Reach Fruition in Illinois Epstein Becker & Green, P.C.
Aug
12
2019
FDA is Asked to Approve Vitamin D3 For Use as a Nutrient Supplement in Grain-Based Nutrition Bars and at Higher Levels Than Currently Affirmed as GRAS in Breakfast Cereals Keller and Heckman LLP
Aug
12
2019
Open Payments Program Expansion Mintz
Aug
10
2019
EPA Releases Draft Risk Evaluation for 1-BP Bergeson & Campbell, P.C.
Aug
9
2019
Seizure Risk Added to E-cigarette Health Warnings Stark & Stark
Aug
9
2019
FSVP Follow-up Keller and Heckman LLP
Aug
8
2019
Year One of Trump’s DOJ: A Closer Look at the Four Main Categories of Offenders Womble Bond Dickinson (US) LLP
Aug
8
2019
In Policy Reversal, HHS and FDA Propose Plan to Import Foreign Drugs Mintz
Aug
8
2019
Working Wise - Volume 1 K&L Gates
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins